Is edaravone harmful? (A placebo is not a control)-Reference-Cited by-同舟云学术

Is edaravone harmful? (A placebo is not a control)

Published:2018-10-02 Issue:7-8 Volume:19 Page:477-482
ISSN:2167-8421
Container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
language:en
Short-container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Author:

Turnbull John¹

Affiliation:

1. Department of Medicine, McMaster University, Hamilton, Canada

Publisher

Informa UK Limited

Subject

Clinical Neurology,Neurology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21678421.2018.1517179

Reference31 articles.

1. Why is ALS so Difficult to Treat?

2. Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients

3. July 2017 ENCALS statement on edaravone

4. Pro-Act Database: https://nctu.partners.org/ProACT. Accessed February 20, 2018. “Data used in the preparation of this article were obtained from the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) Database. In 2011, Prize4Life, in collaboration with the Northeast ALS Consortium, and with funding from the ALS Therapy Alliance, formed the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) Consortium. The data available in the PRO-ACT Database has been volunteered by PRO-ACT Consortium members.”

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased Risk of Venous Thromboembolism in Patients With Amyotrophic Lateral Sclerosis;Neurology Clinical Practice;2023-02

2. Safety and Efficacy of Edaravone in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis;Clinical Drug Investigation;2022-12-03

3. Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design;Neurotherapeutics;2022-07

4. Analysis of the US Safety Data for Edaravone (Radicava®) From the Third Year After Launch;Drugs in R&D;2022-06-20

5. Neuroprotection of Oral Edaravone on Middle Cerebral Artery Occlusion in Rats;Neurotoxicity Research;2022-05-30